AIxMed and Lumea Partner to Enhance Bladder Cancer Diagnostics

AIxMed and Lumea have announced a partnership to integrate AIxMed's AI technology into Lumea's digital pathology platform, enhancing bladder cancer diagnostics.

AIxMed and Lumea have announced a partnership to integrate AIxMed's AI technology into Lumea's digital pathology platform, enhancing bladder cancer diagnostics. In a press release, the companies detailed how AIxMed's AIxURO solution will be incorporated into Lumea's FDA-cleared platform, aiming to improve diagnostic accuracy and workflow efficiency in bladder cancer assessment.

AIxURO is designed to assist in analyzing non-invasive urine cytology specimens, accurately identifying suspicious and atypical cells using The Paris System for Reporting Urinary Cytology. This integration is expected to support clinical decision-making, potentially reducing the need for invasive procedures like cystoscopies and enhancing patient compliance.

Lumea's platform, widely used in the U.S. urology market, will now offer this advanced AI-driven urine cytology solution, further diversifying its offerings for urologists and strengthening its support for comprehensive cancer diagnostic workflows.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish like Life AI Weekly.

Also, consider following us on social media:

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

Superagency in the Workplace: Empowering People to Unlock AI’s Full Potential

This report explores the transformative potential of artificial intelligence in the workplace, emphasizing the readiness of employees versus the slower adaptation of leadership. It highlights the significant productivity growth potential AI offers, akin to historical technological shifts, and discusses the barriers to achieving AI maturity within organizations. The report also examines the role of leadership in steering companies towards effective AI integration and the need for strategic investments to harness AI's full capabilities.

Read more